Davern Capital Partners, LP
•CIK: 2003147•Filing: Q4 2025
**Davern Capital Partners, LP** is a specialized hedge fund managing $309M across 14 concentrated positions. The portfolio exhibits a significant overweighting toward the biotechnology and pharmaceutical sectors, with top holdings including PFE ($50.9M) and REGN ($40.5M). Notable allocations also feature BNTX ($35.3M) and BCLYF ($32.5M), indicating a focused, high-conviction approach within the life sciences value chain.
Total AUM
$309.3M
QoQ Performance
N/A
Positions
14
Top 10 Concentration
90.6%
Latest Filing
Q4 2025
Top Holdings Allocation
PFE
REGN
BNTX
RPRX
ARGX
LEGN
ROIV
ISI
PFE16.4%
REGN13.1%
BNTX11.4%
RPRX10.5%
ARGX9.7%
LEGN7.4%
ROIV7.2%
ISI6.1%
📈 Biggest Buys
📉 Biggest Sells
No reductions this quarter
Sector Breakdown
Other80.7%
Healthcare19.3%